Core Viewpoint - Capri Holdings Limited (NYSE:CPRI) is recognized as one of the best consumer stocks to buy according to Wall Street, despite recent price target reductions by analysts [1]. Group 1: Analyst Ratings and Price Targets - TD Cowen analyst Oliver Chen lowered the price target for Capri Holdings to $26 from $32 while maintaining a Buy rating, citing better-than-expected third-quarter results but noting that elevated expectations are limiting stock performance [2]. - Goldman Sachs reduced its price target to $24 from $27 and kept a Neutral rating, highlighting sequential improvement in Michael Kors full-price sales and strong results at Jimmy Choo, but also mentioning ongoing outlet pressure and a wholesale reset affecting near-term performance [3]. - UBS analyst Jay Sole cut the price target to $22 from $25 while maintaining a Neutral rating, indicating that the company's self-help initiatives are on track but the recovery may take longer than previously expected [3]. Group 2: Financial Performance - Capri Holdings reported third-quarter revenue of $1.025 billion, exceeding the $1 billion consensus estimate, with CEO John Idol emphasizing ongoing strategic initiatives at Michael Kors and Jimmy Choo aimed at long-term growth [4]. - The completed sale of Versace has significantly reduced the company's debt, leaving it with $80 million of net debt at the end of the quarter [4]. Group 3: Company Overview - Capri Holdings Limited is involved in the design, marketing, distribution, and retail of branded women's and men's apparel, footwear, and accessories across various global markets including the United States, Canada, Latin America, Europe, the Middle East, Africa, Asia, and Oceania [5].

Core Viewpoint - The SLM Corporation, also known as Sallie Mae, is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with investors having until February 17, 2026, to seek lead plaintiff status [1]. Company Overview - SLM Corporation, through its subsidiaries, originates and services private education loans (PELs) [2]. Allegations of the Lawsuit - The lawsuit claims that during the class period, SLM made false or misleading statements and failed to disclose significant increases in early-stage delinquencies, leading to an overstatement of the effectiveness of its loss mitigation and loan modification programs [3]. - On August 14, 2025, TD Cowen reported a 49 basis points month-over-month increase in delinquencies for July 2025, which contradicted SLM's CFO's earlier assurances about delinquency rates following normal seasonal trends. Following this report, SLM's stock price fell by approximately 8% [4]. Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who invested in SLM securities during the class period to seek appointment as lead plaintiff, representing the interests of the class [5]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 and $8.4 billion over the past five years [6].

Core Viewpoint - Constellation Energy's stock surged 10.33% this week, driven by significant data center power agreements, positive analyst upgrades, and a renewed focus on nuclear energy's role in supporting AI infrastructure [1]. Group 1: Stock Performance - Constellation Energy (CEG) closed at $288.43 on February 13, recovering from recent losses but still down 18.35% year-to-date [1]. - The stock's 10.33% weekly gain outperformed the broader utilities sector, which saw a 7.27% increase during the same period [1]. - Despite the recent rally, CEG is down 12.7% from $330.38 on January 14, and it trades at a trailing P/E of 32x with a market cap of $100 billion [1]. Group 2: Data Center Power Deals - On February 9, Constellation announced a 380 MW power agreement with CyrusOne for a new Texas data center, with an option for an additional 380 MW, bringing the total commitment to over 1,100 MW [1]. - The company also secured a 20-year agreement with the Tennessee Titans to power the new Nissan Stadium, targeting 20% efficiency improvements [1]. - These agreements highlight Constellation's capability to secure long-term revenue streams linked to infrastructure development for AI and cloud computing [1]. Group 3: Analyst Upgrades - Analysts have issued bullish calls, with Wells Fargo lowering its price target from $478 to $460 but maintaining an Overweight rating, calling CEG the "Best IPP Idea" [1]. - Barclays initiated coverage with a Buy rating and a $356 target, while UBS reiterated its Buy rating with a $420 target [1]. - Zacks Investment Research indicated a +3.13% Earnings ESP for CEG, suggesting a likely earnings beat in the upcoming report [1]. Group 4: Nuclear Energy's Role - The demand for reliable power for AI infrastructure is increasing, with uranium spot prices exceeding $100 per pound in January 2026 due to tightening supply [1]. - The Tennessee Valley Authority has reversed plans to retire coal plants, citing increased electricity demand from data centers and population growth [1]. - Constellation's nuclear fleet produced 46,477 GWhs of nuclear energy in Q3 2025, up from 45,510 GWhs a year earlier, reinforcing its competitive advantage in the energy market [1].

Core Viewpoint - Rigetti Computing's shares have dropped 9.15% this week, reflecting valuation concerns and skepticism about its future performance in the quantum computing sector [1]. Group 1: Performance Overview - Rigetti's stock is down 27.36% year-to-date and 37.44% over the past month, with a peak of $58.15 in mid-October [1]. - The company has a market cap of $4.95 billion and trades at a 660x price-to-sales ratio, with trailing twelve-month revenue of $7.49 million [1]. - Despite a one-year return of 31.35%, recent momentum has reversed significantly [1]. Group 2: Analyst Downgrade - TD Cowen analyst Krish Sankar downgraded Rigetti to Hold, citing unrealistic revenue targets for 2027 and increased costs in the quantum computing field [1]. - The consensus price target for Rigetti is $38.85, indicating potential upside, but the downgrade has shifted market sentiment negatively [1]. - Current estimates for 2027 sales are projected at $45.39 million, with potential downward revisions expected following the downgrade [1]. Group 3: Execution Risks - Rigetti postponed the launch of its Cepheus-1-108Q quantum computer, raising concerns about its technical execution capabilities [1]. - The company reported Q3 revenue of $1.90 million, missing estimates of $2.21 million, and posted a net loss of $200.97 million [1]. - Year-over-year revenue declined by 18.1%, indicating challenges in achieving commercial success [1]. Group 4: Competitive Landscape - IonQ has widened the competitive gap by announcing a significant acquisition to bring quantum hardware manufacturing in-house, reporting Q3 revenue of $39.87 million, which is 20 times that of Rigetti [1]. - IonQ holds $3.5 billion in pro-forma cash after a $2 billion equity offering and has achieved a technical milestone of 99.99% two-qubit gate performance [1]. - The probability of the US government taking an equity stake in Rigetti by the end of 2026 is only 8.05%, compared to 50% for IonQ [1].

Core Viewpoint - Canada's Big Banks are expected to report fourth-quarter results at the end of the month, with analysts expressing caution over stock valuations, which appear stretched compared to historical trends [1] Group 1: Earnings and Performance - The Big Six Canadian banks outperformed U.S. mega-banks and domestic life insurers last year despite a weaker economic outlook and a trade pact review [1] - Analysts at TD Cowen noted that the Big Six are trading at an 18% premium and are approaching full value territory [1] - The stocks are trading at a one-year forward earnings per share of 14.3 times based on 2026 consensus, significantly above the 25-year trend of 10 to 12 times [1] Group 2: Analyst Insights - Despite stretched valuations, TD Cowen analysts believe strong fundamentals, including net interest income, improving U.S. loan growth, and strong trading revenue, will support the sector in the near term [1] - TD Cowen raised price targets for four of the five Big Six banks, with specific adjustments for Bank of Montreal, Bank of Nova Scotia, Canadian Imperial Bank of Commerce, National Bank of Canada, and Royal Bank of Canada [1] Group 3: Price Targets and Recommendations - Bank of Montreal's target rose from $219 to $209, Bank of Nova Scotia from $104 to $112, Canadian Imperial Bank of Commerce from $134 to $142, National Bank of Canada was cut to $175 from $181, and Royal Bank of Canada from $246 to $260 [1] - TD's top bank picks are Bank of Montreal and Royal Bank of Canada due to their extensive U.S. capital markets operations [1]

Core Viewpoint - A class action lawsuit has been filed against SLM Corporation and certain officers for alleged violations of federal securities laws during the Class Period from July 25, 2025, to August 14, 2025, seeking damages for investors who purchased SLM securities during this time [1] Group 1: Lawsuit Details - The lawsuit is filed in the United States District Court for the District of New Jersey, under docket number 25-cv-18834, representing all persons and entities, excluding defendants, who invested in SLM securities during the specified Class Period [1] - Investors have until February 17, 2026, to request appointment as Lead Plaintiff for the class [1] Group 2: Company Overview - SLM Corporation, commonly known as Sallie Mae, primarily originates and services private education loans (PELs) to students and their families, emphasizing its "high-quality" PELs and loss mitigation programs [1] - The company classifies PELs as in repayment when borrowers are making interest-only or fixed payments, or have entered full principal and interest repayment status after any applicable grace period [1] Group 3: Financial Metrics and Concerns - Delinquency rates on SLM's PELs are a critical metric for investors assessing the health and profitability of the business [1] - Defendants allegedly misled investors by attributing rising delinquency rates to "normal seasonal trends" and minor refinements in loan offerings, while failing to disclose significant increases in early-stage delinquencies [1] Group 4: Impact of Findings - On August 14, 2025, TD Cowen reported a 49 basis point month-over-month increase in July 2025 delinquencies, contradicting prior reassurances from SLM's executives [1] - Following the TD Cowen report, SLM's stock price fell by $2.67 per share, or 8.09%, closing at $30.32 per share on August 15, 2025 [1]

Core Viewpoint - Becton Dickinson reported a revenue of $5.89 billion for Q4 FY2025, an 8% year-over-year increase, with adjusted earnings per share of $3.96 exceeding expectations; the total annual revenue reached $21.84 billion, up 8.2% [1] Group 1: Financial Performance - Q4 FY2025 revenue was $5.89 billion, reflecting an 8% year-over-year growth [1] - Adjusted earnings per share for Q4 were $3.96, surpassing market expectations [1] - Total revenue for the fiscal year 2025 was $21.84 billion, marking an 8.2% increase compared to the previous year [1] Group 2: Institutional Perspectives - Citigroup maintained a "Buy" rating with a target price of $232 [2] - TD Cowen raised its target price to $189 while maintaining a "Hold" rating [2] - Other institutions, including Barclays, have also adjusted their target prices, focusing on the company's strategy post-business divestiture [2] Group 3: Stock Performance - The stock experienced significant volatility over the past week, with a cumulative increase of 9.87% and a fluctuation range of 15.58% [3] - On February 11, the closing price was $180.62, with a single-day increase of 5.21% [3] - On February 12, the stock closed at $178.32, reflecting a decrease of 1.27% [3] - Trading activity was robust, with a transaction volume of $1.065 billion on February 11 [3] Group 4: Recent Events - The launch of a Chinese international medical equipment and device trading platform is expected to enhance global expectations for the sector [4] - Waters Corporation completed a merger related to Becton Dickinson's business, resulting in the establishment of four new divisions focused on life sciences and diagnostics [4]

Core Insights - Oracle announced a plan to raise up to $50 billion through bond and equity financing to meet cloud infrastructure demands from major clients like AMD, Meta, and NVIDIA, raising concerns among investors about increasing debt levels [1] - A significant stock price increase occurred following an upgrade in institutional ratings, reflecting short-term optimism regarding Oracle's cloud business prospects [1] - Oracle faces challenges in financing due to difficulties in expanding AI data centers, with several U.S. banks halting loans, leading to plans for layoffs of 20,000 to 30,000 employees and potential sale of its healthcare software division, Cerner [1] Stock Performance - Oracle's stock price exhibited notable volatility over a recent seven-day period, with a closing price of $142.82 on February 6, rising by 9.64% to $156.59 on February 9, and further increasing by 2.11% to $159.89 on February 10, before a slight pullback to $157.16 on February 11, and closing at $155.65 on February 12, resulting in a cumulative increase of 14.05% and a trading range of 19.40% [2] - Despite the recent gains, the stock price has declined approximately 19.92% year-to-date, indicating market caution regarding long-term debt risks [2] Institutional Perspectives - In February 2026, 44 institutions provided ratings on Oracle, with 77% recommending buy or hold, 20% holding, and 3% suggesting sell, indicating a target average price of $276.47, suggesting significant upside potential compared to current stock prices [3] - Bernstein's report on February 12, 2026, posited that even if AI clients like OpenAI completely withdrew, Oracle's valuation floor would be $137 per share, indicating limited downside risk, while an optimistic scenario could see a target price of $313, suggesting that market concerns about AI dependency may be overvalued [3] - D.A. Davidson upgraded its rating to "buy" on February 10, 2026, with a target price of $180, asserting that the core software business valuation has accounted for risks, and the cloud infrastructure business has potential for upward growth [3]

Core Insights - Intuit Inc. (NASDAQ:INTU) is considered one of the most oversold stocks on NASDAQ, with recent price target adjustments from BMO Capital and TD Cowen indicating a potential for recovery despite recent underperformance [1][2] Group 1: Price Target Adjustments - BMO Capital adjusted Intuit's price target to $624 from $810 while maintaining an Outperform rating [1] - TD Cowen revised its price target to $658 from $802, keeping a Buy rating, citing expectations of a clean earnings beat against a low bar due to recent stock underperformance [1] Group 2: Partnership Development - Intuit announced a multi-year partnership with Affirm on February 2, making Affirm the exclusive pay-over-time solution integrated into QuickBooks Payments [2] - This partnership aims to enhance Intuit's financial management capabilities, allowing small and mid-market businesses to offer flexible payment options, thereby maximizing sales and improving cash flow [2] Group 3: Business Segments - Intuit operates in several segments: Small Business and Self-Employed, Consumer, Credit Karma, and ProTax, providing a range of business and financial management solutions [3]

Core Viewpoint - NuScale Power's stock has experienced a significant decline following a downgrade by TD Cowen analyst Marc Bianchi, who shifted the rating from buy to hold due to anticipated negative catalysts affecting the stock [1][4]. Group 1: Stock Performance - NuScale Power's shares fell by 9.3% as of 11:45 a.m. ET on Wednesday [1]. - The stock has already seen a 36% decline over the past year, indicating ongoing investor concerns [1]. Group 2: Project Developments - Nuclearelectrica is expected to make a Final Investment Decision (FID) on its Doicesti Romanian small modular reactor (SMR) project this week, with Bianchi predicting that the project will proceed but with increased risk shifted to NuScale and a potential delay in completion to 2033 or 2034 [2]. - The original completion date was anticipated to be no later than 2030, making this a significant setback for NuScale [2]. Group 3: Market Implications - Bianchi suggests that other nuclear utilities are observing the Doicesti project as a test case for NuScale's commercial viability, which could influence their future decisions [3]. - Delays in the Doicesti project could have cascading effects on the timelines for NuScale's other customers, potentially pushing back the company's expected profitability, which analysts had projected for 2030 [4].